Reminder: VDP Changed PDL Status for "Glucocorticoids, Inhaled" Drug Class on Dec. 15, 2023

Published on

The manufacturer of the brand name Flovent HFA discontinued their products on Dec. 31, 2023. Due to this discontinuation, HHSC removed the non-preferred status from the authorized generic (AG) fluticasone HFA and brand name QVAR Redihaler products, as shown in the table below. These changes allowed providers to prescribe the authorized generic (AG) fluticasone HFA and brand name QVAR Redihaler products without requiring a PDL prior authorization and continue access to necessary medication for members.

NDCDrug Name
66993007896FLUTICASONE PROP HFA 44 MCG
66993007996FLUTICASONE PROP HFA 110 MCG
66993008096FLUTICASONE PROP HFA 220 MCG
59310030240QVAR REDIHALER 40 MCG
59310030480QVAR REDIHALER 80 MCG